The Lancet Commission on pollution and health PJ Landrigan, R Fuller, NJR Acosta, O Adeyi, R Arnold, AB Baldé, ... The lancet 391 (10119), 462-512, 2018 | 4437 | 2018 |
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 920 | 2021 |
Knowns and unknowns on burden of disease due to chemicals: a systematic review A Prüss-Ustün, C Vickers, P Haefliger, R Bertollini Environmental health 10, 1-15, 2011 | 585 | 2011 |
Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 525 | 2022 |
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 481 | 2021 |
Disease mapping and risk assessment for public health. A Lawson, A Biggeri, D Böhning, E Lesaffre, JF Viel, R Bertollini | 468 | 1999 |
Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 445 | 2022 |
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 426 | 2021 |
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 402 | 2022 |
Mass lead intoxication from informal used lead-acid battery recycling in Dakar, Senegal P Haefliger, M Mathieu-Nolf, S Lociciro, C Ndiaye, M Coly, A Diouf, ... Environmental health perspectives 117 (10), 1535-1540, 2009 | 298 | 2009 |
Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe F Valent, R Bertollini, LE Nemer, F Barbone, G Tamburlini The Lancet 363 (9426), 2032-2039, 2004 | 275 | 2004 |
Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ... Clinical Infectious Diseases 73 (7), e1830-e1840, 2021 | 245 | 2021 |
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 241 | 2022 |
A joint international study on the epidemiology of hypospadias. B Källén, R Bertollini, E Castilla, A Czeizel, LB Knudsen, ... Acta Paediatrica Scandinavica. Supplement 324, 1-52, 1986 | 237 | 1986 |
Children’s health and environment: a review of evidence: a joint report from the European Environment Agency and the WHO Regional Office for Europe G Tamburlini, OS von Ehrenstein, R Bertollini Office for Official publications of the European communities, 2002 | 228 | 2002 |
Severity of SARS-CoV-2 reinfections as compared with primary infections LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 385 (26), 2487-2489, 2021 | 192 | 2021 |
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 191 | 2021 |
Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Jama 326 (19), 1930-1939, 2021 | 166 | 2021 |
Birth defects in the Seveso area after TCDD contamination P Mastroiacovo, A Spagnolo, E Marni, L Meazza, R Bertollini, G Segni Jama 259 (11), 1668-1672, 1988 | 165 | 1988 |
Coronavirus disease 2019 disease severity in children infected with the omicron variant AA Butt, SR Dargham, S Loka, RM Shaik, H Chemaitelly, P Tang, ... Clinical Infectious Diseases 75 (1), e361-e367, 2022 | 154 | 2022 |